Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function

Abstract Background The clinical manifestation of ischemia/reperfusion injury in renal transplantation is delayed graft function (DGF), which is associated with an increase in acute rejection episodes (ARE), costs, and difficulties in immunosuppressive management. We sought to evaluated the DGF impa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2011, Vol.43 (1), p.70-73
Hauptverfasser: Requião-Moura, L.R, de Souza Durão, M, Tonato, E.J, Carvalho Matos, A.C, Ozaki, K.S, Câmara, N.O.S, Pacheco-Silva, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 73
container_issue 1
container_start_page 70
container_title Transplantation proceedings
container_volume 43
creator Requião-Moura, L.R
de Souza Durão, M
Tonato, E.J
Carvalho Matos, A.C
Ozaki, K.S
Câmara, N.O.S
Pacheco-Silva, A
description Abstract Background The clinical manifestation of ischemia/reperfusion injury in renal transplantation is delayed graft function (DGF), which is associated with an increase in acute rejection episodes (ARE), costs, and difficulties in immunosuppressive management. We sought to evaluated the DGF impact after renal transplant. Methods We evaluated a group of 628 patients undergoing deceased donor renal transplantation between 2002 and 2005 at 3 Brazilians institutions to define the main DGF characteristics. Results DGF incidence was 56.8%, being associated with elderly donors ( P = .02), longer time on dialysis ( P = .001), and greater cold ischemia time (CIT; P = .001). Upon multivariate analysis, time on dialysis >5 years increased DGF risk by 42% ( P = .02) and CIT >24 hours increased it by 57% ( P = .008). In contrast, DGF was associated with an higher incidence of ARE: 27.7% in DGF versus 18.4% in IGF patients ( P = .047). The ARE risk was 46% higher among individuals with DGF ( P = .02), 44% among patients >45 years old ( P < .001), 50% among those with >5 years of dialysis time ( P = .02), and 47% lower among the who were prescribed mycophenolate instead of azathioprine ( P < .001). Patients with DGF showed worse 1-year graft function (54.6 ± 20.3 vs 59.6 ± 19.4 mL/min; P = .004), particularly those with ARE (55.5 ± 19.3 vs 60.7 ± 20.4; P = .009). One-year graft survival was 88.5% among DGF versus 94.0% among non-DGF patients. Conclusion The high incidence of DGF was mainly associated with a prolonged CIT. There was a relationship between DGF and ARE, as well as with a negative influence on long-term graft function.
doi_str_mv 10.1016/j.transproceed.2010.12.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_853472406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134510019147</els_id><sourcerecordid>853472406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-7ae9a8c016418faf9123e74c516c8605429eafb9b954ea6100d10f9a809fd7683</originalsourceid><addsrcrecordid>eNqNkd-L1DAQgIMo3nr6L0gRxKeumST95YNwnLd3CwuCns8hm040tU3XpBX2v3fK7qHck09JmG9mMt8w9gb4GjiU77v1FE1IhzhaxHYt-BIQaw7iCVtBXclclEI-ZSvOFeQgVXHBXqTUcXoLJZ-zCwFSFlBUK7a5cQ7tlLLRZdtkf-DgTWZCm33BA0Y3Jz-GbBu6OR4zuu3G8D2_xzhkt9G4KdvMwU6EvGTPnOkTvjqfl-zb5ub--i7ffb7dXl_tcltIPuWVwcbUloZQUDvjGhASK2ULKG1d8kKJBo3bN_umUGhK4LwF7iiFN66tylpesnenujT8rxnTpAefLPa9CTjOSdeFVJVQvCTyw4m0cUwpotOH6AcTjxq4XjTqTv-rUS8aNQhNGin59bnNvB8o9pD64I2At2fAJGt6R4WsT385WTe8Lhfu04lDkvLbY9TJegwWWx9Ju25H_3__-fiojO198NT5Jx4xdeMcA2nXoBMl6K_L4pe9k0BoQFXyD74hqv8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>853472406</pqid></control><display><type>article</type><title>Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Requião-Moura, L.R ; de Souza Durão, M ; Tonato, E.J ; Carvalho Matos, A.C ; Ozaki, K.S ; Câmara, N.O.S ; Pacheco-Silva, A</creator><creatorcontrib>Requião-Moura, L.R ; de Souza Durão, M ; Tonato, E.J ; Carvalho Matos, A.C ; Ozaki, K.S ; Câmara, N.O.S ; Pacheco-Silva, A</creatorcontrib><description>Abstract Background The clinical manifestation of ischemia/reperfusion injury in renal transplantation is delayed graft function (DGF), which is associated with an increase in acute rejection episodes (ARE), costs, and difficulties in immunosuppressive management. We sought to evaluated the DGF impact after renal transplant. Methods We evaluated a group of 628 patients undergoing deceased donor renal transplantation between 2002 and 2005 at 3 Brazilians institutions to define the main DGF characteristics. Results DGF incidence was 56.8%, being associated with elderly donors ( P = .02), longer time on dialysis ( P = .001), and greater cold ischemia time (CIT; P = .001). Upon multivariate analysis, time on dialysis &gt;5 years increased DGF risk by 42% ( P = .02) and CIT &gt;24 hours increased it by 57% ( P = .008). In contrast, DGF was associated with an higher incidence of ARE: 27.7% in DGF versus 18.4% in IGF patients ( P = .047). The ARE risk was 46% higher among individuals with DGF ( P = .02), 44% among patients &gt;45 years old ( P &lt; .001), 50% among those with &gt;5 years of dialysis time ( P = .02), and 47% lower among the who were prescribed mycophenolate instead of azathioprine ( P &lt; .001). Patients with DGF showed worse 1-year graft function (54.6 ± 20.3 vs 59.6 ± 19.4 mL/min; P = .004), particularly those with ARE (55.5 ± 19.3 vs 60.7 ± 20.4; P = .009). One-year graft survival was 88.5% among DGF versus 94.0% among non-DGF patients. Conclusion The high incidence of DGF was mainly associated with a prolonged CIT. There was a relationship between DGF and ARE, as well as with a negative influence on long-term graft function.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2010.12.012</identifier><identifier>PMID: 21335157</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Aged ; Azathioprine - administration &amp; dosage ; Biological and medical sciences ; Brazil ; Cadaver ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Graft Survival ; Humans ; Immunosuppressive Agents - administration &amp; dosage ; Kidney Transplantation ; Male ; Medical sciences ; Middle Aged ; Mycophenolic Acid - administration &amp; dosage ; Mycophenolic Acid - analogs &amp; derivatives ; Reperfusion Injury ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue, organ and graft immunology</subject><ispartof>Transplantation proceedings, 2011, Vol.43 (1), p.70-73</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-7ae9a8c016418faf9123e74c516c8605429eafb9b954ea6100d10f9a809fd7683</citedby><cites>FETCH-LOGICAL-c530t-7ae9a8c016418faf9123e74c516c8605429eafb9b954ea6100d10f9a809fd7683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134510019147$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,4010,4036,4037,23909,23910,25118,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23890867$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21335157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Requião-Moura, L.R</creatorcontrib><creatorcontrib>de Souza Durão, M</creatorcontrib><creatorcontrib>Tonato, E.J</creatorcontrib><creatorcontrib>Carvalho Matos, A.C</creatorcontrib><creatorcontrib>Ozaki, K.S</creatorcontrib><creatorcontrib>Câmara, N.O.S</creatorcontrib><creatorcontrib>Pacheco-Silva, A</creatorcontrib><title>Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Background The clinical manifestation of ischemia/reperfusion injury in renal transplantation is delayed graft function (DGF), which is associated with an increase in acute rejection episodes (ARE), costs, and difficulties in immunosuppressive management. We sought to evaluated the DGF impact after renal transplant. Methods We evaluated a group of 628 patients undergoing deceased donor renal transplantation between 2002 and 2005 at 3 Brazilians institutions to define the main DGF characteristics. Results DGF incidence was 56.8%, being associated with elderly donors ( P = .02), longer time on dialysis ( P = .001), and greater cold ischemia time (CIT; P = .001). Upon multivariate analysis, time on dialysis &gt;5 years increased DGF risk by 42% ( P = .02) and CIT &gt;24 hours increased it by 57% ( P = .008). In contrast, DGF was associated with an higher incidence of ARE: 27.7% in DGF versus 18.4% in IGF patients ( P = .047). The ARE risk was 46% higher among individuals with DGF ( P = .02), 44% among patients &gt;45 years old ( P &lt; .001), 50% among those with &gt;5 years of dialysis time ( P = .02), and 47% lower among the who were prescribed mycophenolate instead of azathioprine ( P &lt; .001). Patients with DGF showed worse 1-year graft function (54.6 ± 20.3 vs 59.6 ± 19.4 mL/min; P = .004), particularly those with ARE (55.5 ± 19.3 vs 60.7 ± 20.4; P = .009). One-year graft survival was 88.5% among DGF versus 94.0% among non-DGF patients. Conclusion The high incidence of DGF was mainly associated with a prolonged CIT. There was a relationship between DGF and ARE, as well as with a negative influence on long-term graft function.</description><subject>Adult</subject><subject>Aged</subject><subject>Azathioprine - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Cadaver</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Graft Survival</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Kidney Transplantation</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mycophenolic Acid - administration &amp; dosage</subject><subject>Mycophenolic Acid - analogs &amp; derivatives</subject><subject>Reperfusion Injury</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue, organ and graft immunology</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkd-L1DAQgIMo3nr6L0gRxKeumST95YNwnLd3CwuCns8hm040tU3XpBX2v3fK7qHck09JmG9mMt8w9gb4GjiU77v1FE1IhzhaxHYt-BIQaw7iCVtBXclclEI-ZSvOFeQgVXHBXqTUcXoLJZ-zCwFSFlBUK7a5cQ7tlLLRZdtkf-DgTWZCm33BA0Y3Jz-GbBu6OR4zuu3G8D2_xzhkt9G4KdvMwU6EvGTPnOkTvjqfl-zb5ub--i7ffb7dXl_tcltIPuWVwcbUloZQUDvjGhASK2ULKG1d8kKJBo3bN_umUGhK4LwF7iiFN66tylpesnenujT8rxnTpAefLPa9CTjOSdeFVJVQvCTyw4m0cUwpotOH6AcTjxq4XjTqTv-rUS8aNQhNGin59bnNvB8o9pD64I2At2fAJGt6R4WsT385WTe8Lhfu04lDkvLbY9TJegwWWx9Ju25H_3__-fiojO198NT5Jx4xdeMcA2nXoBMl6K_L4pe9k0BoQFXyD74hqv8</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>Requião-Moura, L.R</creator><creator>de Souza Durão, M</creator><creator>Tonato, E.J</creator><creator>Carvalho Matos, A.C</creator><creator>Ozaki, K.S</creator><creator>Câmara, N.O.S</creator><creator>Pacheco-Silva, A</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2011</creationdate><title>Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function</title><author>Requião-Moura, L.R ; de Souza Durão, M ; Tonato, E.J ; Carvalho Matos, A.C ; Ozaki, K.S ; Câmara, N.O.S ; Pacheco-Silva, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-7ae9a8c016418faf9123e74c516c8605429eafb9b954ea6100d10f9a809fd7683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Azathioprine - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Cadaver</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Graft Survival</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Kidney Transplantation</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mycophenolic Acid - administration &amp; dosage</topic><topic>Mycophenolic Acid - analogs &amp; derivatives</topic><topic>Reperfusion Injury</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue, organ and graft immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Requião-Moura, L.R</creatorcontrib><creatorcontrib>de Souza Durão, M</creatorcontrib><creatorcontrib>Tonato, E.J</creatorcontrib><creatorcontrib>Carvalho Matos, A.C</creatorcontrib><creatorcontrib>Ozaki, K.S</creatorcontrib><creatorcontrib>Câmara, N.O.S</creatorcontrib><creatorcontrib>Pacheco-Silva, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Requião-Moura, L.R</au><au>de Souza Durão, M</au><au>Tonato, E.J</au><au>Carvalho Matos, A.C</au><au>Ozaki, K.S</au><au>Câmara, N.O.S</au><au>Pacheco-Silva, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2011</date><risdate>2011</risdate><volume>43</volume><issue>1</issue><spage>70</spage><epage>73</epage><pages>70-73</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Background The clinical manifestation of ischemia/reperfusion injury in renal transplantation is delayed graft function (DGF), which is associated with an increase in acute rejection episodes (ARE), costs, and difficulties in immunosuppressive management. We sought to evaluated the DGF impact after renal transplant. Methods We evaluated a group of 628 patients undergoing deceased donor renal transplantation between 2002 and 2005 at 3 Brazilians institutions to define the main DGF characteristics. Results DGF incidence was 56.8%, being associated with elderly donors ( P = .02), longer time on dialysis ( P = .001), and greater cold ischemia time (CIT; P = .001). Upon multivariate analysis, time on dialysis &gt;5 years increased DGF risk by 42% ( P = .02) and CIT &gt;24 hours increased it by 57% ( P = .008). In contrast, DGF was associated with an higher incidence of ARE: 27.7% in DGF versus 18.4% in IGF patients ( P = .047). The ARE risk was 46% higher among individuals with DGF ( P = .02), 44% among patients &gt;45 years old ( P &lt; .001), 50% among those with &gt;5 years of dialysis time ( P = .02), and 47% lower among the who were prescribed mycophenolate instead of azathioprine ( P &lt; .001). Patients with DGF showed worse 1-year graft function (54.6 ± 20.3 vs 59.6 ± 19.4 mL/min; P = .004), particularly those with ARE (55.5 ± 19.3 vs 60.7 ± 20.4; P = .009). One-year graft survival was 88.5% among DGF versus 94.0% among non-DGF patients. Conclusion The high incidence of DGF was mainly associated with a prolonged CIT. There was a relationship between DGF and ARE, as well as with a negative influence on long-term graft function.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>21335157</pmid><doi>10.1016/j.transproceed.2010.12.012</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2011, Vol.43 (1), p.70-73
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_853472406
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Aged
Azathioprine - administration & dosage
Biological and medical sciences
Brazil
Cadaver
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Graft Survival
Humans
Immunosuppressive Agents - administration & dosage
Kidney Transplantation
Male
Medical sciences
Middle Aged
Mycophenolic Acid - administration & dosage
Mycophenolic Acid - analogs & derivatives
Reperfusion Injury
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tissue, organ and graft immunology
title Effects of Ischemia and Reperfusion Injury on Long-Term Graft Function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A18%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Ischemia%20and%20Reperfusion%20Injury%20on%20Long-Term%20Graft%20Function&rft.jtitle=Transplantation%20proceedings&rft.au=Requi%C3%A3o-Moura,%20L.R&rft.date=2011&rft.volume=43&rft.issue=1&rft.spage=70&rft.epage=73&rft.pages=70-73&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2010.12.012&rft_dat=%3Cproquest_cross%3E853472406%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=853472406&rft_id=info:pmid/21335157&rft_els_id=S0041134510019147&rfr_iscdi=true